Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Race Oncology Ltd. ( (AU:RAC) ) has issued an update.
Race Oncology Ltd has announced the quotation of 1,425 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of May 22, 2025. This move is part of the company’s ongoing efforts to enhance its market presence and provide liquidity for its stakeholders, potentially impacting its operational dynamics and industry positioning.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 141,613
Technical Sentiment Signal: Buy
Current Market Cap: A$245M
See more insights into RAC stock on TipRanks’ Stock Analysis page.